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Summary
Background.  —  Ranking  of  hospitals  by  lay  media  has  attracted  widespread  attention  but  may
not accurately  reﬂect  quality.  Acute  myocardial  infarction  (AMI)  mortality  is  a  straightforward
measure  of  clinical  outcome  frequently  used  by  ranking  algorithms.
Aims. —  Our  aim  was  to  assess  whether  ranking  among  top  hospitals  correlated  with  lower
in-hospital  risk-adjusted  mortality  following  admission  for  AMI.
Methods.  —  Using  a  hierarchical  regression  model  and  the  comprehensive  nationwide  database
of hospital  AMI  admissions  from  2004  to  2007  in  France,  we  analysed  crude  and  risk-adjusted
hospital  mortality  rates  in  the  ranked  (‘best’)  hospitals  versus  non-ranked  hospitals.  We  subse-
quently  restricted  the  comparison  to  non-ranked  hospitals  with  matching  on-site  facilities.
Results. —  We  analysed  192,372  admissions  in  439  hospitals,  43  of  which  were  in  the  ranked
group. Patients  admitted  to  the  396  non-ranked  hospitals  tended  to  be  older  with  more  comor-
bidities and  underwent  fewer  revascularization  procedures  than  patients  admitted  to  ranked
hospitals. Between  hospital  differences  accounted  for  10%  of  differences  in  mortality.  Crude
Abbreviations: AMI, acute myocardial infarction; PCI, percutaneous coronary intervention; PMSI, French medical information
systems programme.
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mortality  was  lower  in  ranked  versus  non-ranked  hospitals  (7.5%  vs.  11.9%;  P  <  0.001).  The
survival advantage  associated  with  admission  to  ranked  hospitals  was  reduced  after  adjustment
for age  and  sex  (5.7%  vs.  6.4%;  P  =  0.087)  and  comorbidities  (4.9%  vs.  5.5%;  P  =  0.102).
Conclusions.  —  Ranked  hospitals  have  similar  adjusted  AMI  mortality  rates  to  those  not  ranked
and patient  characteristics  rather  than  hospital  differences  account  for  the  variation  in  out-
comes.
© 2012  Elsevier  Masson  SAS.  All  rights  reserved.
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Résumé
Contexte.  —  Le  classement  des  hôpitaux  dans  la  grande  presse  bénéﬁcie  d’un  grand  retentisse-
ment mais  ne  reﬂète  pas  nécessairement  la  qualité  des  soins.  La  mortalité  hospitalière  à  la
phase aiguë  de  l’infarctus  du  myocarde  est  un  indicateur  de  résultat  souvent  utilisé.
Objectifs.  — Notre  objectif  était  de  vériﬁer  l’association  entre  un  bon  classement  des  services
par la  presse  et  la  mortalité  ajustée  de  l’infarctus  du  myocarde.
Méthodes.  —  À  partir  de  la  base  nationale  PMSI  pour  les  années  2004  à  2007,  nous  avons  construit
un modèle  hiérarchique  de  prédiction  de  la  mortalité  à  la  phase  aiguë  de  l’infarctus  du  myocarde
et comparé  dans  un  premier  temps  les  hôpitaux  classés  aux  hôpitaux  non  classés.  Dans  un  second
temps nous  avons  restreint  la  comparaison  aux  hôpitaux  classés  et  non  classés  ayant  un  niveau
d’équipement  comparable.
Résultats.  —  Nous  avons  analysé  192  372  séjours  dans  439  hôpitaux,  parmi  lesquels  43  ﬁguraient
dans le  classement  des  50  meilleurs.  Les  patients  traités  dans  les  396  hôpitaux  non  classés
étaient plus  âgés,  avec  plus  de  comorbidités  et  des  taux  de  revascularisation  inférieurs.  Le
facteur « hôpital  » expliquait  10  %  de  la  mortalité.  La  mortalité  brute  était  plus  basse  dans  les
hôpitaux classés  (7,5  %  vs  11,9  %  ;  p  <  0,001).  L’avantage  de  survie  pour  les  patients  admis  dans
les hôpitaux  classés  diminuait  après  ajustement  sur  l’âge  et  le  sexe  (5,7  %  vs  6,4  %  ;  p  =  0,087)
et les  comorbidités  (4,9  %  vs  5,5  %  ;  p  =  0,102).
Conclusions.  —  La  mortalité  dans  l’infarctus  du  myocarde  est  liée  aux  caractéristiques  du
patient, le  classement  des  hôpitaux  parmi  les  50  meilleurs  ne  prédit  pas  une  meilleure  survie.
© 2012  Elsevier  Masson  SAS.  Tous  droits  réservés.
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hackground
ublic  reporting  of  hospital  performance  is  a  current  pol-
cy  used  by  several  governmental  entities  to  compare
ospital-speciﬁc  or  physician-speciﬁc  outcomes.  California
1],  Pennsylvania  [2],  Scotland  [3]  and  Ontario,  Canada
4],  for  example,  have  released  hospital-speciﬁc  reports  for
ortality  following  admission  for  acute  myocardial  infarc-
ion  (AMI).  While  the  regulatory  and  ﬁnancing  institutions
romote  the  use  of  access  measures  and  disseminate  accred-
tation  reports,  the  lay  press  has  developed  an  annual
ospital  ‘star  rating’  system  that  has  gained  wide  public
cceptance.
In  France,  as  well  as  in  other  countries,  the  criteria
sed  in  lay  press  ranking  differ  from  those  used  for  insti-
utional  public  reporting.  The  yearly  ranking  by  ‘Le  Point’
agazine  is  the  most  widely  circulated  comparison  of  hos-
itals  in  France.  Le  Point  ranks  the  50  ‘best’  hospitals  by
peciality;  the  rank  of  hospitals  that  are  not  among  the
op  50  is  not  disclosed  further.  The  sales  volume  of  the
nnual  edition  of  Le  Point  on  hospital  ranking  has  always
een  the  highest,  except  for  presidential  election  editions.
his  success  probably  stems  from  the  simplicity  of  the  one-
imensional  measure  in  the  ranking  system,  contrary  to
he  multidimensional  and  narrative  assessments  published
y  academic  and  governmental  institutions.  Additionally,
he  Le  Point  ranking  is  performed  by  condition,  on  a  lim-
ted  number  of  conditions  or  procedures  (e.g.  AMI,  hip  or
i
p
t
pnee  replacement,  cataract  surgery  and  prostate  cancer).
esults  are  presented  as  a  list  of  ‘the  best  hospitals  for  AMI
are’  followed  by  another  list  of  ‘the  best  hospitals  for  hip
eplacement’.
Our  objective  was  to  assess  the  robustness  of  this  ranking.
e  selected  AMI  for  the  following  reasons:  while  patients
ho  have  an  AMI  in  France  are  referred  via  the  emergency
mbulance  service  and  do  not  usually  have  the  choice  of
 hospital  and  therefore  would  not  use  the  magazine  rank-
ng,  AMI  care  is  a  proxy  for  cardiac  care  in  general.  In  the
SA,  top-ranked  hospitals  for  AMI  were  found  to  provide
vidence-based  care  for  both  acute  and  non-acute  coro-
ary  syndromes  and  more  generally  to  deliver  care  of  better
uality.  We  examined  whether  being  ranked  in  the  top  50
ospitals  for  care  of  AMI  on  the  Le  Point  list  was  associated
ith  lower  risk-adjusted  in-hospital  mortality  [5].
ethods
sing  the  comprehensive  French  nationwide  hospital
atabase,  we  examined  crude  and  adjusted  hospital  mor-
ality  following  admission  for  AMI  among  the  50  top-ranked
ospitals  on  the  Le  Point  hospital  rating  list  and  compared
t  with  non-ranked  French  hospitals  treating  at  least  10  AMI
atients  per  year.  We  also  performed  a  reverse  analysis  using
he  Le  Point  criteria  to  assess  how  well  they  predicted  hos-
ital  mortality  in  the  total  AMI  population.
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mLay  media  ranking  of  hospitals  
Data source
The  French  medical  information  systems  programme  (PMSI)
ﬁles  for  years  2004—2007  were  used  as  the  data  source  for
this  retrospective  analysis.  The  PMSI  ﬁle  is  an  administrative
database  maintained  by  the  Ministry  of  Health,  containing
all  reimbursement  claims  submitted  by  acute-care  hospitals
(public,  private  not-for-proﬁt  and  private  for-proﬁt,  both
teaching  and  non-teaching).  The  database  records  the  fol-
lowing  information:  patient  age,  sex,  date  of  admission,
date  of  discharge,  primary  diagnosis,  up  to  eight  secondary
diagnoses,  up  to  six  procedures,  discharge  status  and  total
charges.  Linkage  of  multiple  admissions  is  possible.  Out-of-
hospital  mortality,  drugs  on  discharge  and  quality  of  life
measures  are  not  available.  We  also  used  information  on  the
hospitals’  structures  and  equipment  via  the  Annual  Statistics
of  Health  Institutions  database  maintained  by  the  Ministry
of  Health  (statistique  annuelle  des  établissements  de  santé
[SAE]).
Study population
Hospitals
The  population  in  this  study  consisted  of  all  French  public,
private  not-for-proﬁt  and  private  for-proﬁt  hospitals  with
at  least  10  discharges  (each  year)  for  an  AMI,  deﬁned  by
a  principal  diagnosis  code  of  I21—I22  of  the  International
Classiﬁcation  of  Diseases,  Tenth  Revision  (ICD-10)  during  the
years  2004—2007.  Records  were  linked  for  transfers.  The
ﬁrst  step  of  the  selection  process  was  to  exclude  hospitals
for  which  data  on  status  were  missing  or  incomplete;  due  to
statistical  analysis  constraints  (see  below),  the  second  step
excluded  hospitals  with  fewer  than  10  yearly  discharges  for
AMI.  The  comparison  was  repeated  after  restricting  the  anal-
ysis  to  hospitals  with  similar  levels  of  technical  equipment
as  those  found  in  the  top-ranked  hospitals.  Results  of  the
selection  process  are  presented  in  the  ﬂowchart  in  Appendix
1,  together  with  a  description  of  hospitals  and  discharges
excluded  [6].
We  extracted  for  each  hospital:  size  (number  of  beds)
and  activity  (number  of  yearly  admissions  for  I21—I22  ICD-10
diagnoses);  equipment  available  to  treat  cardiology  patients
(i.e.  cardiac  care  unit,  cardiac  surgery  and  catheterization
laboratory);  teaching  and  ownership  status.
Star  rating  system  (Le  Point  rating)
The  ranking  methodology  developed  by  Le  Point  magazine
is  available  online  [7].  In  short,  the  rank  is  a  composite  of
case  volume,  notoriety,  specialization,  percentage  of  outpa-
tient  procedures,  short  length  of  stay,  technical  equipment
and  rate  of  hospital-acquired  infections.  The  weight  given
to  each  item  and  the  aggregation  method  are  not  disclosed.
Only  the  top  50  ranked  hospitals  are  listed  and  ranks  for  the
non-listed  hospitals  are  not  disclosed:  hospitals  are  there-
fore  characterized  by  a  dichotomous  variable  (ranked  versus
not  ranked)  instead  of  a  continuous  rank.  As  far  as  treat-
ment  of  acute  coronary  syndromes  was  concerned,  the  list
of  ranked  hospitals  remained  stable  over  our  study  period.
t
o
w
c491
atients
dmissions  in  the  database  were  linked  to  obtain  patient-
evel  data.  The  primary  purpose  of  the  multilevel  logit  model
as  to  predict  the  probability  of  in-hospital  mortality  during
n  admission  for  AMI,  after  controlling  for  patient  and  hos-
ital  characteristics.  The  following  risk  adjustments  used  a
ierarchical  modelling  approach:  age,  sex,  secondary  diag-
oses,  previous  AMI,  tachycardia,  congestive  heart  failure
nd  renal  failure  [8]  (Appendix  2).
tatistical analysis
 multilevel  analysis  was  performed  to  estimate  the
xpected  probability  of  in-hospital  mortality  and  identify
he  determinants  of  mortality.  This  approach  was  justiﬁed  by
he  hierarchical  structure  of  the  data  comprising  two  levels
f  analysis:  the  hospital  level  and  the  discharge/patient-
evel.  Hierarchical  models  take  into  account  both  the
ariability  between  discharges  and  the  variability  between
ospitals  and  avoid  inappropriate  conclusions  related  to
esidual  variability  when  a  source  of  variability  is  ignored
9].  This  method  also  allowed  determination  of  the  variabil-
ty  attributable  to  each  level  [10].
In  order  to  obtain  unbiased  and  accurate  estimations
sing  this  type  of  model,  a  sufﬁcient  sample  size  at  both  the
ospital  and  the  patient/discharge  levels  is  required,  with
ne  being  dependent  on  the  size  of  the  other.  In  the  absence
f  consensus  regarding  appropriate  sample  size,  we  followed
ecommendations  from  the  literature  [11,12]  in  selecting
ospitals  with  at  least  10  yearly  discharges  on  average  to
nsure  a  sample  with  at  least  40  individuals  per  group.
A  multilevel  logit  model  was  adopted  because  of  the
ichotomous  nature  of  the  dependent  variable  analysed
deceased  versus  alive).  The  model  was  used  to  identify
 signiﬁcant  difference  between  hospitals  with  respect
o  mortality  rates  and  to  determine  the  patient  and
ospital  characteristics  associated  with  an  increased  proba-
ility  of  mortality.  We  subsequently  compared  the  average
n-hospital  mortality  rates  of  ranked  hospitals  versus  non-
anked  hospitals,  ﬁrst  without  adjustment  and  then  after
djusting  for  age,  sex  and  comorbid  conditions.  We  then
estricted  the  comparison  to  hospitals  that  were  equipped
ith  matching  technical  facilities.
We  built  a  multilevel  model  to  predict  mortality  based
n  the  Le  Point  criteria  applied  to  all  hospitals  and  patients.
nly  the  following  variables  were  used  (other  variables  such
s  ‘notoriety’  being  unavailable  to  the  public):  cardiac  care
nit,  cardiac  surgery,  catheterization  lab,  annual  AMI  dis-
harges  and  percentage  of  angioplasty.  We  used  backward
election  because  of  correlation  between  the  variables  of
nterest.
Univariate  differences  were  tested  using  the  Wilcoxon
igned-rank  test.  The  comparison  was  repeated,  focusing
n  the  non-ranked  hospitals  presenting  the  same  structural
haracteristics  as  the  top-ranked  hospitals  (i.e.  general  and
ultidisciplinary  hospitals  equipped  with  at  least  one  ofhree  facilities:  cardiac  surgery,  catheterization  laboratory
r  cardiac  care  unit).  Multilevel  analysis  was  performed
ith  HLM  software  (Scientiﬁc  Software  International,  Lin-
olnwood,  IL,  USA).  All  other  analyses  were  performed  with
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Table  1  Characteristics  of  the  ﬁnal  study  population:  hospitals.
Variables  All  (n  =  439)  Non-ranked  (n  =  396)  Ranked  (n  =  43)  P*
Type
Public  70.6  67.7  97.7
Private  not-for-proﬁt  4.3  4.8  0.0  <  0.001
Private  25.1  27.5  2.3
Status
Public  general  hospital 60.1 63.1  32.6  <  0.001
Private  for-proﬁt/not-for-proﬁt  general  hospital 26.2 29.0 0.0 <  0.001
Regional  hospital 9.8 3.8 65.1 <  0.001
Other 3.9 4.0 2.3 >  0.999
Activity
Occupancy  rate  (%) 82.4  ±  10.6  82.0  ±  11.0  85.8  ±  5.3  0.012
No.  of  full-time  equivalent  cardiologists  4.1  ±  5.1  3.1  ±  3.7  13.6  ±  6.2  <  0.001
No.  of  yearly  admissions  for  AMI 109.6  ±  121.7 80.5  ±  77.9 377.4  ±  125.6  <  0.001
Equipment
Cardiac  care  unit  48.3  43.7  90.7  <  0.001
Cardiac  surgery  11.4  6.4  60.5  <  0.001
No.  of  catheterization  laboratory  units  0.5  ±  0.8  0.4  ±  0.6  1.6  ±  0.9  <  0.001
Other
LOS  (2004—2007)  (days)  6.9  ±  1.8  7.0  ±  1.9  6.7  ±  1.3  0.348
Study  hospitals  ranked  in  top  50:  Le  Point  list  2006  9.8  0  100.0
Data are mean ± standard deviation or %. AMI: acute myocardial infection; LOS: length of stay; PCI: percutaneous coronary intervention.
* Chi2, Wilcoxon or Fisher’s exact test.
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aAS  version  9.1  statistical  software  (SAS  Institute,  Cary,  NC,
SA).
esults
he  study  sample  consisted  of  192,372  patients  treated  in
39  hospitals  over  the  4-year  period.  Hospital  and  patient
haracteristics  are  presented  in  Tables  1  and  2.  Top-ranked
ospitals  were  almost  exclusively  university  hospitals  with
n-site  revascularization  facilities,  admitting  on  average  400
MIs  each  year.  Compared  with  other  hospitals,  they  admit-
ed  more  AMIs  (Fig.  1)  and  their  patients  were  younger,
ore  frequently  men,  presented  fewer  comorbidities  and
ere  more  likely  to  be  treated  with  percutaneous  coronary
ntervention  (PCI).  The  average  length  of  stay  (2004—2007)
as  6.9  ±  1.8  days  for  all  patients,  7.0  ±  1.9  days  for  patients
n  non-ranked  hospitals  and  6.7  ±  1.2  days  for  patients  in
anked  hospitals.
nalysis of mortality data
he  average  in-hospital  mortality  rate  over  the  4-year  period
as  8.85%,  decreasing  from  13.8%  in  2004  to  9.4%  in  2006
nd  8.1%  in  2007.  There  was  a  large  variation  in-hospital
ortality  rates  between  hospitals,  ranging  from  0.02%  to
3%.  Over  90%  of  the  hospitals  had  a  mortality  rate  below
0%,  while  26  hospitals  had  a  mortality  rate  above  20%
Fig.  2).
i
t
s
eigure 1. Frequency of ranked and non-ranked hospitals by aver-
ge acute myocardial infarction (AMI) admissions.
esults of the multilevel model
esults  of  the  empty  model
he  empty  model  did  not  contain  any  explanatory  variables
nd  estimated  the  proportion  of  variation  in  mortal-
ty  at  the  hospital  level.  The  intercept  was  −2.05  and
he  variance  component  of  the  random  effect  was  0.37,
igniﬁcantly  different  from  0  (P  <  0.001),  indicating  the
xistence  of  mortality  differences  related  to  hospitals.
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Table  2  Characteristics  of  the  ﬁnal  study  population:  patients.
Variables  All  (n  =  192,372)  Non-ranked
(n  =  125,896)
Ranked
(n  =  66,476)
P*
Age  (%)
55 years  or  less  22.6  20.2 27.3
56—65  years  16.2  16.3 19.1
66—75  years  21.5  21.3 21.9  <  0.001
76—85  years  26.5  28.6 23.3
86  years  and  over 11.8 13.5 8.3
Sex  ratio
Men/women 2.1  1.8  2.3  <  0.001
Comorbidities  (%)
History  of  AMI 5.2  5.3  6.3  <  0.001
History  of  other  coronary  disease  27.5  26.1 29.6  <  0.001
Valvular  heart  disease 6.1  6.6  5.1  <  0.001
Rhythm/conduction  disorder 18.4  19.7 15.8  <  0.001
Hypertension 36.2  36.2 36.2  0.829
Heart  failure 18.1  19.3 15.1  <  0.001
Stroke 3.6  4.0  3.0  <  0.001
Peripheral  artery  disease 6.1  6.1  6.1  0.784
Other  circulatory  disease 2.8  2.8  2.9  0.739
Renal  failure 7.8  7.8  8.0  0.952
Diabetes 18.0  18.2 17.5  <  0.001
Primary  diagnosis  (%)
AMI  (I21)  97.9  97.6 98.4  <  0.001
Recurrent  AMI  (I22)  2.1  2.4%  1.6
Management  (%)
Coronarography  55.0  47.1 70.5  <  0.001
PCI  alone  43.8  37.3 56.5
CABG  0.8  0.5  1.3
PCI  and  CABG  0.1  0.1  0.1  <  0.001
Other  (thrombolysis  or  no  revascularization)  55.3  62.1 42.0
Mortality  (in-hospital)  (%) 8.8  9.6  7.4  <  0.001
AMI: acute myocardial infarction; CABG: coronary artery bypass graft; PCI: percutaneous coronary intervention.
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The  model  estimated  that  hospital  variations  accounted
for  approximately  10%  of  the  total  unexplained  variance,
which  means  that  the  existing  mortality  variations  were
explained  by  differences  between  hospitals  (intraclass  cor-
relation  =  0.101).
Results  of  the  multilevel  patient/discharge  model
The  patient  variables  positively  associated  with  mortality
were  age  (with  a  relative  6%  increase  in  mortality  risk  every
year),  female  sex  (associated  with  a  4%  increase  in  mortal-
ity,  independent  of  age),  recurrent  AMI  (associated  with  a
42%  increase  in  mortality)  and  an  earlier  year  of  admission.
Higher  AMI  volume  was  associated  with  risk  reduction,  with
odds  ratios  ranging  from  0.82  for  yearly  case  volume  supe-
rior  to  100  to  0.77  for  yearly  case  volume  superior  to  250
(P  =  0.002).  Adjustment  for  age  and  sex  (step  1)  and  comor-
bidities  (step  2)  reduced  the  mortality  difference  between
hospitals.  After  adjustment  for  age  and  sex,  over  90%  of
the  hospitals  had  a  mortality  rate  below  10%,  while  26
o
n
aospitals  (6%)  had  a  mortality  rate  above  10%  (Fig.  2  and
ables  3  and  4).
ortality in ranked versus non-ranked
ospitals
f  the  50  top-ranked  hospitals  for  cardiac  care,  43  were  part
f  our  database,  totalling  64,916  patients.  The  seven  miss-
ng  hospitals  were  either  part  of  a  hospital  consortium  that
id  not  release  individual  institution’s  characteristics  (n  =  2)
r  were  excluded  because  of  missing  structure  and  equip-
ent  data  (n  =  5).  These  43  top-ranked  hospitals  differed
rom  the  rest  of  the  hospitals  with  respect  to  the  following
n-site  facilities:  coronary  care  unit  91%  [39/43]  vs.  43.7%  in
he  other  hospitals;  cardiac  surgery  department  60%  [26/43]
s.  6.1%  in  the  other  hospitals;  cardiac  catheterization  lab-
ratory  95%  [41/43]  vs.  27%  in  the  other  hospitals.
In-hospital  mortality  (Fig.  3)  was  lower  in  ranked  versus
on-ranked  hospitals  (7.5%  vs.  11.9%;  P  <  0.001).  The  survival
dvantage  associated  with  admission  to  top-ranked  hospitals
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oigure 2. Mortality rate by hospital, estimated from the hierarch
rude mortality, age/sex-adjusted mortality and age/sex/comorbid
as  reduced  by  adjustment  for  age  and  sex  (5.7%  vs.  6.4%;
 =  0.087)  and  comorbidities  (4.9%  vs.  5.5%;  P  =  0.102).
We  restricted  the  comparison  to  the  168  similarly
quipped  hospitals  with  matching  on-site  facilities  for
evascularization  and  the  corresponding  125,896  patients.
imilarly  equipped  hospitals  admitted  on  average  122  ±  99
MIs  yearly  (vs.  377  ±  125  in  ranked  hospitals),  their  patient
opulation  was  older  than  in  ranked  hospitals  (69.5  ±  15
s.  66.1  ±  15  years)  and  their  average  length  of  stay  was
.1  ±  1.5  days.  Compared  with  similarly  equipped  hospi-
als,  ranked  hospitals  performed  more  revascularizations
PCI  or  coronary  artery  bypass  graft):  56.6%  vs.  33.8%
atients.  Crude  unadjusted  in-hospital  mortality  was  lower
n  ranked  hospitals  than  in  similarly  equipped  hospitals
7.5%  vs.  10.9%;  P  <  0.001)  (Fig.  4).  Adjustment  for  age,  sex
nd  comorbidities  reduced  the  mortality  advantage:  5.4%
s.  6.0%  (P  =  0.063)  and  4.6%  vs.  5.2%  (P  =  0.078)  (Fig.  5).
hen  revascularization  was  added  to  the  adjustment,  the
ortality  difference  was  reversed,  with  a  higher  mortal-
ty  in  ranked  versus  non-ranked  hospitals  (9.5%  vs.  8.1%;
 =  0.0033).ortality in ranked hospitals
dditionally,  comparison  of  the  level  of  adjusted  mortality
ithin  ranked  hospitals  (Fig.  6)  showed  that  there  was  no
s
p
w
wodel: entire population of acute myocardial infarction discharges,
djusted mortality (n = 192,372 discharges and 439 hospitals).
elation  between  this  and  the  level  of  a  hospital  rank  in  the
e  Point  rating  (kappa  =  0.0  between  hospital  ranks  and  their
djusted  mortality  ranks).
se of the Le Point criteria to predict
ortality
mong  all  explicit  variables  in  the  Le  Point  ranking,  the  per-
entage  of  angioplasty  had  the  greatest  protective  effect
odds  ratio  0.23;  P  <  0.001),  followed  by  the  presence  of
 cardiac  care  unit  (odds  ratio  0.87;  P  =  0.004).  The  other
ariables  did  not  predict  mortality  in  the  full  dataset.
iscussion
ur  analysis  of  AMI  in-hospital  mortality  in  439  hospitals  and
92,372  AMI  admissions  found  that  top-ranked  hospitals  have
imilar  adjusted  AMI  mortality  rates  to  those  not  ranked  and
hat  hospital  differences  account  for  a  small  fraction  of  the
ariations.  Differences  between  hospitals  accounted  for  10%
f  the  differences  in  mortality.  A  substantial  portion  of  the
urvival  advantage  of  patients  admitted  to  top-ranked  hos-
itals  was  explained  by  demographics  and  comorbidities  as
ell  as  higher  use  of  revascularization.  In  other  words,  there
as  no  evidence  that  patients  who  had  an  AMI  increased
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Table  3  Results  of  the  multilevel  patient/discharge  model.a
Variable  Estimate  P  Estimated  OR  95%  CI  (OR)
Intercept —2.28  <  0.001
Age  0.06  <  0.001  1.06  1.061—1.065
Sex  (ref.  male)
Female  0.04  0.022  1.04  1.006—1.078
Primary  diagnosis  (ref.  AMI)
Recurrent  myocardial  infarction 0.35  <  0.001  1.42  1.250—1.611
Management  (ref.  other  thrombolysis  or  no  revascularization)
CABG —0.21  NS 0.81 0.614—1.066
PCI  alone —0.86  <  0.001 0.42  0.395—0.449
PCI  and  CABG  0.68  0.003  1.98  1.272—3.087
Year  of  discharge  (ref.  2004)
2005  0.03  NS  1.03  0.983—1.081
2006  0.01  NS  1.01  0.954—1.063
2007  —0.14  <  0.001  0.87  0.826—0.922
Patients  with  more  than  one  discharge  (control)  (ref.  no) <  0.001
AMI: acute myocardial infarction; CABG: coronary artery bypass graft; CI: conﬁdence interval; NS: not signiﬁcant; OR: odds ratio; PCI:
percutaneous coronary intervention; ref.: referent.
The variable identifying patients with more than one discharge was introduced as a control variable.
a The odds ratios are derived from the estimates.
Table  4  Results  of  the  multilevel  model,  including  age,  sex  and  comorbid  conditions.
Variable  Estimate  P  OR  95%  CI  (OR)
Intercept —2.85  <  0.001
Age  0.06  <  0.001  1.065  1.063—1.067
Sex  (ref.  male)
Female 0.11  <  0.001  1.12  1.083—1.158
Tachycardia 0.20 <  0.001  1.22  1.163—1.289
Congestive  heart  failure 0.30 <  0.001 1.35  1.278—1.429
Renal  failure 0.60 <  0.001  1.82  1.713—1.941
CI: conﬁdence interval; OR: odds ratio; ref.: referent.
Deﬁnitions for covariates: ICD-10 code on the discharge summary.
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atheir  likelihood  of  survival  if  they  chose  a  star-rated  hospi-
tal  rather  than  any  hospital  admitting  over  100  patients  with
AMI  per  year  and  equipped  with  the  appropriate  facilities.
Our  data  are  consistent  with  prior  observations  on  the
importance  of  case  volume  and  on  the  role  of  on-site  revas-
cularization  facilities  [5,13,14].  Other  authors  found  similar
limitations  in  the  rankings  produced  by  the  United  States
News  and  World  Report  or  consumer-orientated  websites
[5,15—18].  In  their  2006  study  of  ‘Hospital  Compare’  ratings,
Werner  and  Bradlow  reported  that  ‘[a]cross  all  performance
measures  for  heart  attack,  the  difference  between  the  top-
and  bottom-rated  hospitals  was  0.5%  for  inpatient  mortality,
0.6%  for  30-day  mortality  and  1.2%  for  1-year  mortality.  The
difference  in  30-day  mortality  rates  for  top-rated  hospitals
for  all  heart  attack  measures  versus  bottom-rated  hospitals
for  all  measures  was  1.1%’  [19]. There  is,  nevertheless,  evi-
dence  pointing  in  the  opposite  direction,  with  a  relationship
between  AMI  mortality  and  hospital  quality;  in  that  case,
b
C
o
eowever,  quality  of  care  was  assessed  by  disease-speciﬁc
ndicators  instead  of  global  hospital  scores  and  reporting  was
ot  entrusted  to  the  lay  press.
tudy limitations
echnical  limitations  of  our  study  result  from  the  admin-
strative  dataset  itself.  Full  adjustment  for  confounders
s  limited  by  the  fact  that  the  French  national  discharge
atabase  does  not  currently  provide  reliable  information  on
omorbid  conditions  to  allow  full  risk  adjustment  as  recom-
ended  by  other  authors,  nor  does  it  provide  information
n  non-interventional  treatments  received  or  AMI  severity
t  admission  [20]. The  poor  quality  of  coding  for  comor-
id  conditions  has  been  reported  previously  [21]. In  the
RUSADE  study,  investigators  noted  that  ‘nearly  two-thirds
f  patient  medical  records  did  not  discuss  comorbid  dis-
ases  (such  as  diabetes  mellitus,  hypertension  or  smoking)
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Figure 3. A. Mortality comparison (%) between ranked (n = 43) and
non-ranked (n = 396) hospitals; risk adjustments based on the hierar-
chical model. B. Mortality comparison between ranked (n = 43) and
non-ranked (n = 396) hospitals; box plots corresponding to A.
Figure 4. Mortality comparison between ranked and non-ranked
hospitals, excluding non-ranked hospitals lacking basic require-
ments for the management of acute myocardial infarction patients
(i.e. cardiac care unit, cardiac surgery or catheterization labora-
tory).
Figure 5. Mortality comparison between ranked (n = 43) and non-
ranked (n = 125) hospitals.
SAE données administratives — ministère chargé de la Santé et des
Sports, DREES.
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oigure 6. Mortality rate of ranked hospitals by adjusted mortality
ank (n = 43).
espite  the  prevalence  of  these  conditions  in  the  treated
opulation’  [22]. This  coding  issue  explains  the  difﬁculties
ncountered  by  risk  adjustment  models,  although  its  real
ower  to  explain  the  variability  in  mortality  could  be  chal-
enged  [23]. At  this  stage,  we  are  unable  to  disentangle  what
ertains  to  hospital  quality  from  what  pertains  to  patient
everity  in  a  decision  to  undertake  PCI.  The  hospital  coding
ystem  did  not  differentiate  PCI  from  primary  PCI,  which
as  found  to  be  an  important  predictor  of  mortality  [14].
Another  limitation  was  the  exclusion  of  hospitals  with
issing  data  and  hospitals  with  fewer  than  10  AMI  discharges
er  year.  Gale  et  al.  [6]  showed  that  a  high  proportion
f  missing  data  is  associated  with  worse  30-day  mortal-
ty  rates  and  that  missing  data  affected  the  calculation  of
tandardized  mortality  rates.  Missing  hospital  data  in  our
ataset  did  not  concern  any  of  the  top-ranked  hospitals  nor
he  similarly  equipped  hospitals.  The  exclusion  of  very-low-
olume  hospitals  was  both  a  technical  decision,  because
ultilevel  modelling  does  not  provide  valid  estimates  with-
ut  a  minimum  set  of  observations,  and  a  political  decision
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[Lay  media  ranking  of  hospitals  
on  our  part  because  these  hospitals  are  not  meant  to  treat
AMI.
A  ﬁnal  limitation  was  the  indicator  itself:  supposing  that
it  could  be  made  to  reﬂect  accurately  hospital  differences,  it
remains  a  ‘simplistic’  index  that  does  not  account  for  many
important  aspects  of  quality  of  care  and  may  not  be  the
appropriate  gold  standard  to  judge  the  quality  of  a  ranking
system.  We  chose  mortality  because  of  the  current  politi-
cal  focus  on  (adjusted)  mortality  rates  [13,24].  The  French
Minister  of  Health  was  requested  in  2010  by  the  President
to  ensure  reporting  of  in-hospital  mortality,  thus  following
the  lead  of  England,  the  USA,  Canada,  the  Netherlands  and
Sweden,  despite  the  ongoing  controversy  regarding  the  use
of  in-hospital  mortality  to  monitor  quality  [25].
Conclusions
There  is  public  demand  for  hospital  rankings,  as  evidenced
by  the  overwhelming  success  of  the  published  rankings  and
their  spread  across  most  news  magazines  in  France  and
elsewhere  in  the  world.  Despite  evidence  of  the  risk  of  mis-
classiﬁcation  and  its  potential  negative  consequences  for
hospitals  or  physicians,  news  magazines  appear  determined
to  pursue  such  rankings.  This  abundance  can  be  viewed  as
a  welcome  endeavour  to  increase  transparency  and  respond
to  patients’  requests  [26,27]  but  it  can  also  create  confu-
sion  among  patients  [15,28]  when,  as  shown  in  our  example,
objective  indicators  and  ranking  do  not  coincide.
In  the  end,  while  hospital  rankings  in  the  lay  press  are
likely  to  persist  because  of  public  demand,  provision  by
academic  institutions  of  information  on  how  good  these  indi-
cators  are  in  predicting  outcomes  that  matter  and  innovative
methods  to  assess  performance  (Gale  BMC)  should  ensure
that  hospital  ratings  are  consistent  with  improvement  in-
hospital  quality.
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